In contrast to FGF23 neutralizing antibodies and prolonged pan-FGFR blockade that have been shown to cause hyperphosphatemia, tissue calcification and increased mortality27, 28, the specific FGFR4 blocking antibody did not interfere with serum phosphate levels. Here, FGF23 is linked to hyperphosphatemia.